Vericiguat and health status outcomes in heart failure with reduced ejection fraction: insights from the VICTORIA trial

被引：0

作者：

Butler, J. ^{[1
]}

Stebbins, A. ^{[2
]}

Melenovsky, V. ^{[3
]}

Sweitzer, N. ^{[4
]}

Cowie, M. R. ^{[5
]}

Stehlik, J. ^{[6
]}

Ezekowitz, J. A. ^{[7
]}

Hernandez, A. F. ^{[2
]}

Lam, C. S. P. ^{[8
]}

Nkulikiyinka, R. ^{[9
]}

O'Connor, C. M. ^{[10
]}

Pieske, B. ^{[11
]}

Ponikowski, P. ^{[12
]}

Voors, A. A. ^{[13
]}

Armstrong, P. W. ^{[7
]}

机构：

[1] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA

[2] Duke Clin Res Inst, Durham, NC USA

[3] Inst Clin & Expt Med IKEM, Prague, Czech Republic

[4] Univ Arizona, Sarver Heart Ctr, Tucson, AZ USA

[5] Imperial Coll London, London, England

[6] Univ Utah, Salt Lake City, UT USA

[7] Univ Alberta, Edmonton, AB, Canada

[8] Duke Natl Univ Singapore, Natl Heart Ctr Singapore, Singapore, Singapore

[9] Bayer AG, Wuppertal, Germany

[10] Inova Heart & Vasc Inst, Falls Church, VA USA

[11] Charite Campus Virchow Klinikum CVK, Berlin, Germany

[12] Wroclaw Med Univ, Wroclaw, Poland

[13] Univ Med Ctr Groningen, Groningen, Netherlands

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：786 / 786

页数：1